What's on the Horizon for Myasthenia Gravis – Cell-based therapies, broader B-cell targeting, and immune tolerance are all in the works
Major advances in treatment options have been game-changers for people diagnosed with myasthenia gravis (MG). Experts comment on current MG treatment methods, as well as exciting new research.Source: Medpage Today
A Changing Treatment Landscape in Myasthenia Gravis – A spate of new approvals set off a "revolution" in management
Following a wave of new approvals in recent years, adults with generalized myasthenia gravis (gMG) now have a wider variety of treatment options to manage their symptoms.Source: Medpage Today
Health Headlines: Doctors expect stroke deaths to increase worldwide
The World Health Organization predicts that annual deaths from stroke around the world will reach 10 million by 2050. Hardik Amin, MD, board-certified vascular neurologist and medical stroke director at Yale New Haven Hospital, discussed with WTNH News 8 the symptoms of stroke, the importance of seeking immediate medical care, and how to lower the risk of stroke.Source: WTNH News 8
'Our America: Unforgettable'
Alzheimer's disease is a devastating neurodegenerative disease that not only damages the memory and identity of the people who suffer from it, but their loved ones as well. This ABC News documentary explores the impact of Alzheimer's disease on the Latinx community and pulls on the knowledge of experts in the field, including Yale Assistant Professor of Neurology Carmen Carrión, PsyD, a neuropsychologist with vast experience treating diverse patient populations.Source: ABC News
Christine Gummerson, MD Honored as Consultant of the Year
The Department of Emergency Medicine has honored Christine Gummerson, MD, a PGY4 resident in the Department of Neurology, with the Consultant of the Year Award. By voting for her to receive this award, the residents in the Departmtent of Emergency Medicine have specifically acknowledged Dr. Gummerson not only for her outstanding dedication to her myriad responsibilities as a consultant, but also for her unwavering professionalism and commitment to improving the lives of her patients.
Cyprien Rivier, MD, MSc Wins ESOC Young Research Investigator Award in Stroke
Postdoctoral Research Fellow Cyprien Rivier, MD, MSc wins the Young Research Investigator Award in Stroke at the European Stroke Organisation Conference. Dr. Rivier was recognized as an outstanding early-career researcher whose research makes significant contributions to our understanding of stroke.
Soumya Yandamuri, MSE, PhD Wins 2023 Yale Mentoring Award
Postdoctoral Fellow Soumya Yandamuri, MSE PhD is one of five recipients of the 2023 Yale Mentoring Award. The award recognizes Dr. Yandamuri's exceptional dedication to mentoring undergraduates and graduates in the O'Connor Lab, as well as graduate students in the Women in Science at Yale program.
NeurologyLive® Clinician of the Month Spotlight: Jason J. Sico, MD, MHS
Yale's Jason Sico, MD, MHS is NeurologyLive's Clinician of the Month for June. In this interview, Dr. Sico, a neurologist with additional clinical training in headache, brain injury medicine, and stroke, describes his myriad responsibilities as a neurologist and his dedication to improving lives through evidence-based therapies, particularly the veteran community.Source: NeurologyLive
Raising Awareness for World Multiple Sclerosis Day
In honor of World MS Day on May 30, 2023, Yale Department of Neurology Chair and neuro-immunologist David Hafler, MD spoke with NBC Connecticut on the importance of early detection of MS, advances in effective therapies, and improvements in prognosis over the last 30 years.Source: NBC Connecticut
A Staring Spell
Hal Blumenfeld, MD, PhD, Yale School of Medicine professor of neurology and director of the Yale Clinical Neuroscience Imaging Center, describes the journey of validating an animal for measuring behavioral response during absence epilepsy, understanding the neuronal basis for the condition, and the path toward identifying targeted therapies.Source: Yale Scientific
Study Finds Sleeping Pill Can Reduce Proteins Linked to Alzheimer's Disease
A recent study in "Annals of Neurology" suggests that sleeping pill, suvorexant (Belsomra), may decrease the levels of two key proteins linked with Alzheimer's disease. While the study is promising, Yale's Amran Fesharaki-Zadeh, MD, PhD notes that further clinical trials are needed to understand this connection.Source: healthline
Nowak Receives Impact Award
The Myasthenia Gravis Foundation of America (MGFA) has awarded its Impact Award to Richard Nowak, MD for his exceptional leadership, collaboration, innovation, and dedication to advancing the mission of the MGFA. Dr. Nowak was formally recognized at the 2023 MGFA National Patient Conference in New Orleans, La.
When the Patient Is a ‘Very Important Person’: How to Handle the Ethical and Clinical Minefields of VIP Syndrome
When neurologists are asked to prioritize care for so-called VIPs—donors, trustees, politicians, and celebrities—it can complicate medical decision-making. Neurologists who focus on neuroethics discuss the ethical and clinical issues that emerge when providing VIP treatment to patients and how health care providers can address those concerns.Source: Neurology Today
Migraine: A Neurological Condition That's Not Just in Your Head
In this video, Associate Professor of Neurology Jason Sico, MD, MHS describes the unique symptoms that set migraine apart as not being a “normal” headache and as a condition that profoundly affects quality of life. Dr. Sico also notes new developments in medications and other treatment options, and not only encourages patients to speak openly with their doctor, but also for doctors to take migraine seriously.Source: Yale Medicine YouTube
Yale School of Medicine researchers study ‘magic mushroom’ treatment for migraines
Christopher Gottschalk, MD, professor and chief of the division of general neurology at the Yale School of Medicine discusses research led by Emmanuelle Schindler, MD on the therapeutic effects of psilocybin on headache disorders.Source: WTNH News 8
Yale Research on Psychedelics Gives Hope to Headache Disorder Community
Medical Director of the Headache Center of Excellence at the West Haven VA Medical Center and Assistant Professor of Neurology Emmanuelle Schindler, MD, PhD is the only researcher in the United States studying psychedelics in headache disorders. Her pioneering research on the therapeutic effects of psilocybin on disorders such as cluster headache and partnership with a patient support group is giving hope to a misunderstood and misdiagnosed patient population.
Yale Team Cycles with Parkinson’s Foundation
On February 25, 2023, people with Parkinson’s, caregivers, allies, and healthcare providers from the Yale Comprehensive Parkinson's Disease Program participated in an indoor cycling event at CycleBar in West Hartford to raise awareness and funds for the Parkinson's Foundation.
MRI FOR ALL: Portable low-field scanners could revolutionize medical imaging in nations rich and poor—if doctors embrace them
In an interview with Science magaine, Yale's Kevin Sheth, MD says that the smaller size, versatility, and low cost of the Swoop portable MRI by Hyperfine has the potential to revolutionize medical imaging in the United States and abroad. Winning over physicians and patients is the next step in expanding the machine's use in clinical settings.Source: Science